MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues.
about
Cancer microRNAs: from subtype profiling to predictors of response to therapyMicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and BevacizumabHigh-throughput miRNA profiling of human melanoma blood samples.Optimization and analysis of a quantitative real-time PCR-based technique to determine microRNA expression in formalin-fixed paraffin-embedded samples.MicroRNA isolation from formalin-fixed, paraffin-embedded tissuesTranscriptome profiling reveals miR-9-3p as a novel tumor suppressor in gastric cancerFactors affecting the yield of microRNAs from laser microdissectates of formalin-fixed tissue sections.Systematic expression profiling analysis identifies specific microRNA-gene interactions that may differentiate between active and latent tuberculosis infection.Mirna expression profiles identify drivers in colorectal and pancreatic cancers.Transcriptional profiling of formalin fixed paraffin embedded tissue: pitfalls and recommendations for identifying biologically relevant changes.Small RNA expression profiling by high-throughput sequencing: implications of enzymatic manipulation.Evaluation of microRNA expression in patient bone marrow aspirate slides.Small RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are?The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanomamiRNA Profiling: How to Bypass the Current Difficulties in the Diagnosis and Treatment of SarcomasNovel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primaryAnalysis of microRNA from archived formalin-fixed paraffin-embedded specimens of amyotrophic lateral sclerosisMicroRNA in Melanoma.Identification of serum microRNA biomarkers for tuberculosis using RNA-seqDeveloping a prognostic micro-RNA signature for human cervical carcinoma.Small RNA sequencing for profiling microRNAs in long-term preserved formalin-fixed and paraffin-embedded non-small cell lung cancer tumor specimens.Therapeutic Opportunities for Targeting microRNAs in Cancer.Prediction of desmoid tumor progression using miRNA expression profilingCurrent genetic methodologies in the identification of disaster victims and in forensic analysisDecreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma.Fluorescence In Situ Hybridization for MicroRNA Detection in Archived Oral Cancer TissuesProteomic analysis of formalin-fixed paraffin-embedded pancreatic tissue using liquid chromatography tandem mass spectrometryA second-generation microRNA-based assay for diagnosing tumor tissue origin.C/D-box snoRNA-derived RNA production is associated with malignant transformation and metastatic progression in prostate cancer.Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE Specimens.Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas.High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancerMicroRNA expression in formalin-fixed paraffin embedded tissue using real time quantitative PCR: the strengths and pitfalls.MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.MicroRNA expression profiles in the management of papillary thyroid cancer.Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms.A proteomic comparison of formalin-fixed paraffin-embedded pancreatic tissue from autoimmune pancreatitis, chronic pancreatitis, and pancreatic cancer.MicroRNAs in hepatic pathophysiology in diabetes.Enhanced MAPK signaling drives ETS1-mediated induction of miR-29b leading to downregulation of TET1 and changes in epigenetic modifications in a subset of lung SCCEnrichment of A Rare Subpopulation of miR-302-Expressing Glioma Cells by Serum Deprivation.
P2860
Q24594739-30150B19-1BD7-42EC-A5C4-D8613A9189B5Q30415894-FD33635E-6E0C-4F76-BDD6-B4E3494C61E8Q33596719-BD24B59F-67E5-464B-BB68-633228E0F850Q33614363-B2B01293-8D2D-4295-B668-E74C6F2DECAEQ33836012-656147D7-8ADF-4E6A-8315-993DB871823CQ33913929-1010C3F9-3F51-49B7-8EF9-D7940ADDBC06Q34133281-EA7780DA-3AFA-40F4-9AB5-B921D4E7E158Q34207222-2755EE40-E53B-4D60-8717-9F25C5C7353DQ34221558-5C1A5B57-8D82-4BF3-914F-7D6BA935B490Q34243648-6AC7FD4C-19BF-485F-A718-329F94A1767EQ34332016-32C6A8D0-AE79-496F-B62E-08CF476D0901Q34389101-670D394D-CD87-49E6-82D7-CCEBD3B067F5Q34405044-FD68858D-0B58-4484-A008-CAFBE847E3EBQ34459058-41B3D99A-A22B-4D4E-A1C3-85140D5CFB4EQ34700668-E341791D-D06E-4AFD-B071-7A61C29C0AF9Q34768554-E368A360-2C08-4C85-9C15-042F096DA253Q34788620-EE6ADF56-7B8A-4F35-BA90-E75ED9526C25Q34986222-DD36A77D-B51A-46B4-885D-EFB7C11340A2Q35106435-791DFB69-C76C-4F66-8B5E-5DED166C5527Q35447762-DCE5BE89-085E-4033-9740-5CB3F2D3A130Q35587812-C593811F-BBB3-4E55-B754-E13A42610124Q35673914-442559EE-F972-4ECB-A57D-8BF33FBD7DE3Q35674236-8A2F0C28-261D-47D5-A030-ACEF118972E0Q35693617-679DCEF7-23B3-4703-BA3E-647936753398Q35919253-F64524C5-08A2-402F-B8E8-4E203FF39779Q35986596-C90ED1A8-A6BC-4E75-9B55-9F3D58F9CE0EQ36011264-5A6AA301-46D9-4F34-AC81-3DCA4303D3B0Q36051505-21B9B06C-B772-439F-802B-804AE6B05ABCQ36232068-095C49FB-7B23-483E-B0F6-DB70D29B5925Q36320751-A1F2C277-F2E8-40E0-B060-979449C5B39AQ37312706-8DA41641-66F6-4456-BCD0-F2FB3269D9B7Q37626488-CE8B7E49-C89D-45E9-9C85-3CDB61F0E885Q37946394-E133CB5F-7368-41D9-B240-79FB491F7462Q38018308-F9D23F41-F566-48E6-862F-4CCCF2AAB620Q38260896-BFA47FB8-A344-455F-9883-D785D43663B3Q38319885-2F78DBE0-1128-4D32-819E-13B190E6A862Q38395698-9A9AE5D3-6E7E-4915-8DB6-6B6735B61BDDQ38751634-6D5EF43A-3588-4AFA-ADC6-3FD5768DB05BQ38802689-750B47D8-DFFB-4078-AAFC-869211CEBC6EQ38909172-030027EB-4E22-4A3B-AFAB-C06868567CD1
P2860
MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
MicroRNA expression profiling ...... xed paraffin-embedded tissues.
@en
type
label
MicroRNA expression profiling ...... xed paraffin-embedded tissues.
@en
prefLabel
MicroRNA expression profiling ...... xed paraffin-embedded tissues.
@en
P2093
P2860
P1476
MicroRNA expression profiling ...... ixed paraffin-embedded tissues
@en
P2093
Antonia R Sepulveda
David Elder
John W Tobias
Michael Feldman
Michael T Tetzlaff
Pat Vanbelle
Xiaowei Xu
P2860
P304
P577
2009-03-20T00:00:00Z